EdgarLookup

EPLUS INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that EPLUS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
5.2%
Profit Margin
Net income ÷ revenue
5.7%
Return on Assets
Net income ÷ assets
0.93x
Debt-to-Equity
Total liabilities ÷ equity
-7%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $2.07B May 22, 2025
FY2025 Mar 31, 2024 $2.23B May 22, 2025
FY2025 Mar 31, 2023 $2.07B May 22, 2025
FY2024 Mar 31, 2022 $1.82B May 23, 2024
FY2023 Mar 31, 2021 $1.57B May 25, 2023
FY2020 Mar 31, 2020 $366.48M May 22, 2020
FY2020 Dec 31, 2019 $428.99M May 22, 2020
FY2020 Sep 30, 2019 $411.57M May 22, 2020
FY2020 Jun 30, 2019 $381.37M May 22, 2020
FY2020 Mar 31, 2019 $325.43M May 22, 2020

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2018 Mar 31, 2018 $330.43M May 25, 2018
FY2018 Dec 31, 2017 $342.57M May 25, 2018
FY2018 Sep 30, 2017 $370.85M May 25, 2018
FY2018 Jun 30, 2017 $367.16M May 25, 2018
FY2018 Mar 31, 2017 $332.77M May 25, 2018
FY2018 Dec 31, 2016 $326.66M May 25, 2018
FY2018 Sep 30, 2016 $371.46M May 25, 2018
FY2018 Jun 30, 2016 $298.50M May 25, 2018
FY2018 Mar 31, 2016 $1.20B May 25, 2018

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Mar 31, 2017 $332.77M May 25, 2017
FY2017 Dec 31, 2016 $326.66M May 25, 2017
FY2017 Sep 30, 2016 $371.46M May 25, 2017
FY2017 Jun 30, 2016 $298.50M May 25, 2017
FY2017 Mar 31, 2016 $299.40M May 25, 2017
FY2017 Dec 31, 2015 $298.64M May 25, 2017
FY2017 Sep 30, 2015 $336.29M May 25, 2017
FY2016 Jun 30, 2015 $269.87M May 26, 2016
FY2016 Mar 31, 2015 $267.27M May 26, 2016
FY2016 Dec 31, 2014 $306.24M May 26, 2016

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $569.12M May 22, 2025
FY2025 Mar 31, 2024 $550.79M May 22, 2025
FY2025 Mar 31, 2023 $517.52M May 22, 2025
FY2024 Mar 31, 2022 $460.98M May 23, 2024
FY2023 Mar 31, 2021 $393.55M May 25, 2023
FY2020 Mar 31, 2020 $91.83M May 22, 2020
FY2020 Dec 31, 2019 $103.70M May 22, 2020
FY2020 Sep 30, 2019 $103.03M May 22, 2020
FY2020 Jun 30, 2019 $92.64M May 22, 2020
FY2020 Mar 31, 2019 $81.27M May 22, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $107.98M May 22, 2025
FY2025 Mar 31, 2024 $115.78M May 22, 2025
FY2025 Mar 31, 2023 $119.36M May 22, 2025
FY2024 Mar 31, 2022 $105.60M May 23, 2024
FY2023 Mar 31, 2021 $74.40M May 25, 2023
FY2020 Mar 31, 2020 $13.25M May 22, 2020
FY2020 Dec 31, 2019 $19.55M May 22, 2020
FY2020 Sep 30, 2019 $20.10M May 22, 2020
FY2020 Jun 30, 2019 $16.19M May 22, 2020
FY2020 Mar 31, 2019 $15.05M May 22, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $141.41M May 22, 2025
FY2025 Mar 31, 2024 $158.26M May 22, 2025
FY2025 Mar 31, 2023 $166.16M May 22, 2025
FY2024 Mar 31, 2022 $147.32M May 23, 2024
FY2023 Mar 31, 2021 $106.34M May 25, 2023
FY2020 Mar 31, 2020 $17.88M May 22, 2020
FY2020 Dec 31, 2019 $26.27M May 22, 2020
FY2020 Sep 30, 2019 $28.38M May 22, 2020
FY2020 Jun 30, 2019 $22.76M May 22, 2020
FY2020 Mar 31, 2019 $14.47M May 22, 2020

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $399.74M May 22, 2025
FY2025 Mar 31, 2024 $367.73M May 22, 2025
FY2025 Mar 31, 2023 $333.52M May 22, 2025
FY2024 Mar 31, 2022 $297.12M May 23, 2024
FY2023 Mar 31, 2021 $271.26M May 25, 2023
FY2020 Mar 31, 2020 $69.78M May 22, 2020
FY2020 Dec 31, 2019 $73.09M May 22, 2020
FY2020 Sep 30, 2019 $70.52M May 22, 2020
FY2020 Jun 30, 2019 $65.79M May 22, 2020
FY2020 Mar 31, 2019 $62.68M May 22, 2020

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $302.15M May 22, 2025
FY2025 Mar 31, 2024 $248.45M May 22, 2025
FY2025 Mar 31, 2023 ($15.43M) May 22, 2025
FY2024 Mar 31, 2022 ($20.57M) May 23, 2024
FY2023 Mar 31, 2021 $129.51M May 25, 2023
FY2022 Mar 31, 2020 ($74.17M) May 26, 2022
FY2021 Mar 31, 2019 $39.41M May 21, 2021
FY2020 Mar 31, 2018 $82.77M May 22, 2020
FY2019 Mar 31, 2017 $33.02M May 23, 2019
FY2018 Mar 31, 2016 $14.11M May 25, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $1.88B May 22, 2025
FY2025 Mar 31, 2024 $1.65B May 22, 2025
FY2024 Mar 31, 2023 $1.41B May 23, 2024
FY2023 Mar 31, 2022 $1.17B May 25, 2023
FY2023 Mar 31, 2021 $1.08B May 25, 2023
FY2022 Mar 31, 2020 $909.11M May 26, 2022
FY2021 Mar 31, 2019 $786.20M May 21, 2021
FY2020 Mar 31, 2018 $755.47M May 22, 2020
FY2019 Mar 31, 2017 $741.72M May 23, 2019
FY2018 Mar 31, 2016 $616.68M May 25, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $907.18M May 22, 2025
FY2025 Mar 31, 2024 $751.69M May 22, 2025
FY2024 Mar 31, 2023 $632.56M May 23, 2024
FY2023 Mar 31, 2022 $505.47M May 25, 2023
FY2022 Mar 31, 2021 $514.37M May 26, 2022
FY2021 Mar 31, 2020 $422.97M May 21, 2021
FY2020 Mar 31, 2019 $361.95M May 22, 2020
FY2019 Mar 31, 2018 $382.87M May 23, 2019
FY2018 Mar 31, 2017 $395.80M May 25, 2018
FY2017 Mar 31, 2016 $297.80M May 25, 2017

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $977.62M May 22, 2025
FY2025 Mar 31, 2024 $901.78M May 22, 2025
FY2025 Mar 31, 2023 $782.27M May 22, 2025
FY2025 Mar 31, 2022 $660.74M May 22, 2025
FY2024 Mar 31, 2021 $562.41M May 23, 2024
FY2023 Mar 31, 2020 $486.15M May 25, 2023
FY2022 Mar 31, 2019 $424.25M May 26, 2022
FY2021 Mar 31, 2018 $372.60M May 21, 2021
FY2020 Mar 31, 2017 $345.92M May 22, 2020
FY2019 Mar 31, 2016 $318.88M May 23, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $202.86M May 22, 2025
FY2025 Mar 31, 2024 $161.50M May 22, 2025
FY2024 Mar 31, 2023 $136.11M May 23, 2024
FY2023 Mar 31, 2022 $126.54M May 25, 2023
FY2023 Mar 31, 2021 $126.65M May 25, 2023
FY2022 Mar 31, 2020 $118.10M May 26, 2022
FY2021 Mar 31, 2019 $110.81M May 21, 2021
FY2020 Mar 31, 2018 $76.62M May 22, 2020
FY2019 Mar 31, 2017 $48.40M May 23, 2019
FY2018 Mar 31, 2016 $42.15M May 25, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $850.96M May 22, 2025
FY2025 Mar 31, 2024 $742.98M May 22, 2025
FY2024 Mar 31, 2023 $627.20M May 23, 2024
FY2023 Mar 31, 2022 $507.85M May 25, 2023
FY2022 Mar 31, 2021 $484.62M May 26, 2022
FY2021 Mar 31, 2020 $410.22M May 21, 2021
FY2020 Mar 31, 2019 $341.14M May 22, 2020
FY2019 Mar 31, 2018 $277.95M May 23, 2019
FY2018 Mar 31, 2017 $222.82M May 25, 2018
FY2017 Mar 31, 2016 $331.22M May 25, 2017

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $389.38M May 22, 2025
FY2025 Mar 31, 2024 $253.02M May 22, 2025
FY2024 Mar 31, 2023 $103.09M May 23, 2024
FY2023 Mar 31, 2022 $155.38M May 25, 2023
FY2022 Mar 31, 2021 $129.56M May 26, 2022
FY2021 Mar 31, 2020 $86.23M May 21, 2021
FY2020 Mar 31, 2019 $79.82M May 22, 2020
FY2019 Mar 31, 2018 $118.20M May 23, 2019
FY2018 Mar 31, 2017 $109.76M May 25, 2018
FY2018 Mar 31, 2016 $94.77M May 25, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 $38.77M May 22, 2025

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 4 May 22, 2025
FY2025 Mar 31, 2024 4 May 22, 2025
FY2025 Mar 31, 2023 4 May 22, 2025
FY2024 Mar 31, 2022 3 May 23, 2024
FY2023 Mar 31, 2021 2 May 25, 2023
FY2020 Mar 31, 2020 0 May 22, 2020
FY2020 Dec 31, 2019 1 May 22, 2020
FY2020 Sep 30, 2019 1 May 22, 2020
FY2020 Jun 30, 2019 1 May 22, 2020
FY2020 Mar 31, 2019 1 May 22, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 4 May 22, 2025
FY2025 Mar 31, 2024 4 May 22, 2025
FY2025 Mar 31, 2023 4 May 22, 2025
FY2024 Mar 31, 2022 3 May 23, 2024
FY2023 Mar 31, 2021 2 May 25, 2023
FY2020 Mar 31, 2020 0 May 22, 2020
FY2020 Dec 31, 2019 1 May 22, 2020
FY2020 Sep 30, 2019 1 May 22, 2020
FY2020 Jun 30, 2019 1 May 22, 2020
FY2020 Mar 31, 2019 1 May 22, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Mar 31, 2025 26.53M May 22, 2025
FY2025 Mar 31, 2024 26.95M May 22, 2025
FY2024 Mar 31, 2023 26.91M May 23, 2024
FY2023 Mar 31, 2022 26.89M May 25, 2023
FY2022 Mar 31, 2021 27.01M May 26, 2022
FY2021 Mar 31, 2020 13.50M May 21, 2021
FY2020 Mar 31, 2019 13.61M May 22, 2020
FY2019 Mar 31, 2018 13.76M May 23, 2019
FY2018 Mar 31, 2017 14.16M May 25, 2018
FY2017 Mar 31, 2016 14.73M May 25, 2017